C M BIDWELL & ASSOCIATES LTD - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 299 filers reported holding HAEMONETICS CORP in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
C M BIDWELL & ASSOCIATES LTD ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$81,655
-3.1%
9870.0%0.06%
-3.5%
Q1 2024$84,240
+23.5%
987
+23.7%
0.06%
+11.8%
Q4 2023$68,237
-68.1%
798
-66.6%
0.05%
-68.7%
Q3 2023$214,007
+25.9%
2,389
+19.7%
0.16%
+31.5%
Q2 2023$169,939
+2.9%
1,9960.0%0.12%
-0.8%
Q1 2023$165,169
+120.2%
1,996
+166.1%
0.12%
+54.3%
Q4 2018$75,000
-28.6%
750
-18.5%
0.08%
-18.2%
Q3 2018$105,000
+8.2%
920
-15.2%
0.10%
+10.0%
Q2 2018$97,000
+21.2%
1,085
-1.4%
0.09%
+23.3%
Q1 2018$80,0001,1000.07%
Other shareholders
HAEMONETICS CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders